Clinical impact of differential risk stratification by breast cancer index (BCI) versus recurrence score (RS) in HR+ early-stage breast cancer: A TransATAC study.
Ivana Sestak
No relevant relationships to disclose
Yi Zhang
Employment or Leadership Position - bioTheranostics
Stock Ownership - bioTheranostics
Catherine A. Schnabel
Employment or Leadership Position - bioTheranostics
Stock Ownership - bioTheranostics
Brock Schroeder
Employment or Leadership Position - bioTheranostics
Stock Ownership - bioTheranostics
Mark Erlander
Consultant or Advisory Role - bioTheranostics
Stock Ownership - bioTheranostics
Honoraria - bioTheranostics
Paul E. Goss
No relevant relationships to disclose
Jack M. Cuzick
Consultant or Advisory Role - NanoString Technologies
Research Funding - bioTheranostics
Mitchell Dowsett
Consultant or Advisory Role - Genoptix; NanoString Technologies
Research Funding - AstraZeneca
Dennis Sgroi
No relevant relationships to disclose